Researchers have identified an experimental compound that effectively burns fat while preserving muscle mass, offering a potential alternative to current weight-loss medications like Ozempic.
The drug works by boosting metabolic heat production without suppressing appetite, a mechanism that distinguishes it from existing GLP-1 receptor agonists.
Clinical trials are currently in the early stages, with scientists aiming to validate the drug's long-term safety and efficacy in human subjects.